Literature DB >> 11747827

Competition for BLyS-mediated signaling through Bcmd/BR3 regulates peripheral B lymphocyte numbers.

S M Harless1, V M Lentz, A P Sah, B L Hsu, K Clise-Dwyer, D M Hilbert, C E Hayes, M P Cancro.   

Abstract

Striking cell losses occur during late B lymphocyte maturation, reflecting BcR-mediated selection coupled with requisites for viability promoting signals. How selection and survival cues are integrated remains unclear, but a key role for B lymphocyte stimulator (BLyS(TM); trademark of Human Genome Sciences, Inc.) is suggested by its marked effects on B cell numbers and autoantibody formation as well as the B lineage-specific expression of BLyS receptors. Our analyses of the B cell-deficient A/WySnJ mouse have established Bcmd as a gene controlling follicular B cell life span, and recent reports show Bcmd encodes a novel BLyS receptor. Here we show that A/WySnJ B cells are unresponsive to BLyS, affording interrogation of how Bcmd influences B cell homeostasis. Mixed marrow chimeras indicate A/WySnJ peripheral B cells compete poorly for peripheral survival. Moreover, in vivo BrdU labeling shows that (A/WySnJ x BALB/c)F(1) B cells have an intermediate but uniform life span, indicating viability requires continuous signaling via this pathway. Together, these findings establish the BLyS/Bcmd pathway as a dominant mediator of B cell survival, suggesting competition for BLyS/Bcmd signals regulates follicular B cell numbers.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11747827     DOI: 10.1016/s0960-9822(01)00598-x

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  56 in total

Review 1.  Peripheral B cell selection and homeostasis.

Authors:  Michael P Cancro; Susan Harless Smith
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

Review 2.  Translational Mini-Review Series on B cell subsets in disease. Transitional B cells in systemic lupus erythematosus and Sjögren's syndrome: clinical implications and effects of B cell-targeted therapies.

Authors:  A Vossenkämper; P M K Lutalo; J Spencer
Journal:  Clin Exp Immunol       Date:  2012-01       Impact factor: 4.330

Review 3.  Homeostatic control of B lymphocyte subsets.

Authors:  Jenni E Crowley; Jean L Scholz; William J Quinn; Jason E Stadanlick; John F Treml; Laura S Treml; Yi Hao; Radhika Goenka; Patrick J O'Neill; Andrew H Matthews; Ronald F Parsons; Michael P Cancro
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

4.  BLyS inhibition eliminates primary B cells but leaves natural and acquired humoral immunity intact.

Authors:  Jean L Scholz; Jenni E Crowley; Mary M Tomayko; Natalie Steinel; Patrick J O'Neill; William J Quinn; Radhika Goenka; Juli P Miller; Yun Hee Cho; Vatana Long; Chris Ward; Thi-Sau Migone; Mark J Shlomchik; Michael P Cancro
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-01       Impact factor: 11.205

5.  FcgammaRIIB signals inhibit BLyS signaling and BCR-mediated BLyS receptor up-regulation.

Authors:  Jenni E Crowley; Jason E Stadanlick; John C Cambier; Michael P Cancro
Journal:  Blood       Date:  2008-09-12       Impact factor: 22.113

Review 6.  B lymphocyte stimulator protein levels in systemic lupus erythematosus and other diseases.

Authors:  William Stohl
Journal:  Curr Rheumatol Rep       Date:  2002-08       Impact factor: 4.592

Review 7.  B cells and transplantation: an educational resource.

Authors:  Trudy N Small; William H Robinson; David B Miklos
Journal:  Biol Blood Marrow Transplant       Date:  2009-01       Impact factor: 5.742

8.  Global T cell dysregulation in non-autoimmune-prone mice promotes rapid development of BAFF-independent, systemic lupus erythematosus-like autoimmunity.

Authors:  William Stohl; Noam Jacob; William J Quinn; Michael P Cancro; Huaxin Gao; Chaim Putterman; Xiaoni Gao; Luminita Pricop; Michael N Koss
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

9.  Systemic autoimmunity in BAFF-R-mutant A/WySnJ strain mice.

Authors:  Christopher G Mayne; Ian J Amanna; Faye E Nashold; Colleen E Hayes
Journal:  Eur J Immunol       Date:  2008-02       Impact factor: 5.532

10.  DeltaBAFF, an alternate splice isoform that regulates receptor binding and biopresentation of the B cell survival cytokine, BAFF.

Authors:  Amanda L Gavin; Djemel Aït-Azzouzene; Carl F Ware; David Nemazee
Journal:  J Biol Chem       Date:  2003-07-16       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.